SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could fall sharply in 2027 has fueled a steep selloff in CorMedix shares. Traders are split between viewing the comments as a serious threat to DefenCath revenue and arguing DaVitas outlook is preliminary and may not reflect CMSs current reimbursement estimates.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing treatment for recurrent respiratory papillomatosis has raised concerns about competition for Precigens PAPZIMEOS. Traders debate the threat to sales against Precigens first-mover and full-approval advantages, established commercialization, and Inovios remaining work to confirm benefit and build its launch.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs run to a fresh 52-week high is drawing attention ahead of an expected, but not confirmed, Q3 earnings report, with traders pointing to BRIUMVI growth and possible short covering. Buyout speculation is also prominent but unconfirmed, and the community differs on whether earnings expectations or takeover hopes are driving the move.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is being swept up in a sharp semiconductor selloff, with traders pointing to Intels weak outlook and broader tech-market pressure. The reaction is mixed: some see the drop as an overdone sector-driven move and are buying the dip, while others remain cautious about Qualcomms growth outlook and upcoming earnings.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings beat, supported by demand for Eylea HD and Sanofi collaboration revenue, is driving a sharp rally and breakout to new highs. Traders are broadly celebrating the results, while some are watching to see whether the stock can hold its gains.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A stronger-than-expected third-quarter report and raised revenue outlook, driven by demand for Mounjaro and Zepbound, are fueling LLYs rally and analyst optimism. Traders are bullish on its GLP-1 franchise and pipeline, while some question the stocks valuation and point to lower profit guidance tied to acquisition-related charges.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Positioning around Shopifys Q3 earnings is driving discussion, with traders weighing the companys growth and AI-commerce prospects against its valuation and the risk of a volatile report. The stocks sharp swings have also prompted debate over whether its recent pullback is a buying opportunity or a sign of further weakness.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transoceans advancing Valaris merger and recent offshore drilling contract wins are fueling attention, with traders also watching higher day rates and upcoming earnings. Bulls see merger progress and elevated short interest as potential support for a continued move, while skeptics point to debt, dilution, and a history of fading gains.

Happen, Inc. is a U.S. digital marketplace bank focused on the Motivated Middle high FICO, high-income borrowers actively managing their financial lives. The firm’s success is fueled by advanced credit underwriting, a proprietary technology platform, and a marketplace bank model that generates compelling revenue through loan sales, net interest income, and fee-based services. It operates through the LendingClub Bank and LendingClub Corporation (Parent Only) segments. The LendingClub Bank segment is involved in the provision of a full complement of financial products and solutions, loans, leases, and deposits. The LendingClub Corporation (Parent Only) segment includes the holding company legal entity. The company was founded by Renaud Laplanche and Soulaiman Htite on October 2, 2006 and is headquartered in San Francisco, CA.

Happen Inc.

Happens Q3 results beat estimates and the company raised its full-year outlook, drawing attention to stronger originations, profitability, and credit trends. Traders are split: some see the results and buybacks as supportive, while others say the outlook is cautious and question why the share price remains weak despite the report.

BankrCoin (BNKR) is a cryptocurrency and operates on the Base platform. BankrCoin has a current supply of 100,000,000,000 with 99,389,999,999.99966667 in circulation. The last known price of BankrCoin is 0.00029512 USD and is up 9.48 over the last 24 hours. It is currently trading on 84 active market(s) with $2,292,823.67 traded over the last 24 hours. More information can be found at https://warpcast.com/bankr.

BankrCoin

BNKRs rally is fueling speculation, with traders citing Bankrs expanding AI-agent infrastructure and chain integrations, along with staking and protocol-funded buybacks, as potential sources of value. Sentiment is largely bullish, but some traders warn that the token remains volatile and question whether the gains can hold amid selling pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Poor $NKE getting hammered down to a $50B market cap while it has more than double the operating profit as fucking $PLTR at a $478B market cap. I get paying some for growth but what a fucking clown world we live in now. Invest in overvalued garbage tech because it’ll just keep going and sell historically incredible brands. $SPY $QQQ

The Put Guru

Dee Osinski

StockTwits for iOS

Nike Inc

Palantir Technologies Inc

 getting hammered down to a $50B market cap while it has more than double the operating profit as fucking 

 at a $478B market cap. I get paying some for growth but what a fucking clown world we live in now. Invest in overvalued garbage tech because it’ll just keep going and sell historically incredible brands. 

VulgarBear

@VulgarBear nike will definitely have its day in the sun again. When it does. People who have been buying at these levels will be grateful they did.

StockTwits Web

 nike will definitely have its day in the sun again. When it does. People who have been buying at these levels will be grateful they did.

YourMudHer

@VulgarBear poor Nike my ass! They went woke and supported every leftist cause they could. Too stupid to be believed. Haha—go broke! Love it

 poor Nike my ass! They went woke and supported every leftist cause they could. Too stupid to be believed. Haha—go broke! Love it